FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to phthisiology, and can be used in treating patients with drug-sensitive respiratory tuberculosis with stage 5 chronic kidney disease without bacterial excretion. Before starting the treatment, the necessary examinations are carried out, after which the patients are divided into 2 groups depending on the extent of the tuberculosis process, the type of renal replacement therapy, as well as the presence of a comorbid pathology. During the treatment, each group receives chemotherapy with four- and three-component phases and anti-tuberculosis drugs caused by the type of renal replacement therapy.
EFFECT: invention enables to select an optimal treatment strategy providing an effective result in tuberculosis processes of various severity.
3 cl, 5 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR FORMING A CHEMOTHERAPY REGIMEN FOR PRIMARY INTRATHORACIC TUBERCULOSIS IN CHILDREN FROM TUBERCULOSIS INFECTION CENTERS | 2018 |
|
RU2704816C1 |
| METHOD FOR DETERMINING THE DURATION OF AN INTENSIVE PHASE OF CHEMOTHERAPY OF RESPIRATORY TUBERCULOSIS IN CHILDREN WITHOUT BACTERIAL RELEASE AND WITHOUT A RISK OF MULTIPLE AND BROAD DRUG RESISTANCE OF TUBERCULOSIS MYCOBACTERIA | 2020 |
|
RU2737337C1 |
| METHOD FOR SELECTING SHORTENED CHEMOTHERAPY REGIMENS FOR THE TREATMENT OF PULMONARY TUBERCULOSIS | 2022 |
|
RU2805496C1 |
| METHOD OF DETERMINING THE TIMING OF SURGICAL INTERVENTION WHEN USING SHORT COURSES OF CHEMOTHERAPY FOR THE TREATMENT OF PULMONARY TUBERCULOSIS | 2022 |
|
RU2798945C1 |
| METHOD FOR FORMATION OF SHORTENED REGIMENS OF CHEMOTHERAPY FOR RESPIRATORY TUBERCULOSIS WITH MULTIPLE AND EXTENSIVE DRUG RESISTANCE OF MBT IN OLDER CHILDREN AND ADOLESCENTS | 2020 |
|
RU2748957C1 |
| PULMONARY TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2195313C1 |
| METHOD FOR SELECTING SHORTENED CHEMOTHERAPY REGIMENS IN THE TREATMENT OF RESPIRATORY TUBERCULOSIS IN CHILDREN FROM FOCI WITH MULTIDRUG RESISTANCE OF THE PATHOGEN | 2022 |
|
RU2784464C1 |
| METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS | 2024 |
|
RU2830337C1 |
| Pleurotus 1137 PREPARATION FOR DRUG HYPERSENSITIVITY CORRECTION IN INTEGRATED THERAPY OF PULMONARY TUBERCULOSIS | 2010 |
|
RU2435600C1 |
| METHOD FOR DETERMINING DURATION OF CHEMOTHERAPY OF RESPIRATORY TUBERCULOSIS WITH MULTIPLE AND WIDE MTB DRUG RESISTANCE IN CHILDREN AND TEENAGERS | 2018 |
|
RU2680972C1 |
